Page 2 - Sheppard Mullin Capabilities Overview Prepared for Regeneron
P. 2
CONTENTS
Sheppard Mullin Team ............................................................................................................................3 Firm Overview ..........................................................................................................................................4 Life Sciences .............................................................................................................................................6 FDA Regulatory ........................................................................................................................................8 Corporate and Securities .....................................................................................................................10 Due Diligence .........................................................................................................................................12 Healthcare Privacy and Security ........................................................................................................14 Healthcare Market Access ...................................................................................................................15 Healthcare.................................................................................................................................................17 Investigations ..........................................................................................................................................20 False Claims Act .....................................................................................................................................22 Import/Export...........................................................................................................................................24 Sanctions .................................................................................................................................................26 Diversity & Inclusion ..............................................................................................................................27 Innovation Tools .....................................................................................................................................35
